Basel, October 29, 2024 – Novartis announced today that Scemblix ® (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients with newly diagnosed ...

The opioid addiction treatment market will be worth $2.4bn by 2033, driven by diagnoses in the eight major world markets.

OKYO Pharma has initiated the Phase II trial of OK-101, a treatment for neuropathic corneal pain (NCP), by dosing the first ...

The company ... diagnostic technology (99.99 percent), marks the widespread distribution of a groundbreaking technology capable of diagnosing cancer from just a drop of blood. “The company is ...

The company intends ... other exchanges. This innovative tokenization initiative aims to revolutionize the mining sector by providing a new financing model for mining operations by leveraging the ...

The global leukemia therapeutics treatment market has seen considerable growth, progressing from USD 14,504.8 million in 2022 to USD 15,246.7 million in 2023. With a projected compound annual growth ...

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today ...

Based on RNA technology, ICON’s new assay offers huge improvements on how CML is monitored ... NGS assay known as Dup-Seq BCR::ABL1. This innovative assay enables the identification of both ...

Join the CML Book Club! The CTV Morning Live hosts will share a new title each month. Read along, share your thoughts, and recommend your favourite books. The CML Book Club’s first selection is ...

Despite rallying today after its CEO stepped down, Wisetech had a chilling effect on the entire ASX 200, which is ... Read ...

Hosted by Investor Relations Officer Richard Cathcart, the episode features an in-depth conversation about Mercado Libre's ...